Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !
AMN Healthcare Services Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
AMN Healthcare ServicesDer Umsatz des Unternehmens wird voraussichtlich um 1.8% pro Jahr sinken, während der Jahresgewinn um 18.2% pro Jahr wachsen wird. Der Gewinn pro Aktie wird voraussichtlich wachsen um 14.4% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 17.1% betragen.
Wichtige Informationen
17.7%
Wachstumsrate der Gewinne
13.9%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 17.3% |
| Wachstumsrate der Einnahmen | -1.9% |
| Zukünftige Eigenkapitalrendite | 17.1% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 06 Jun 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
AMN Healthcare Services (NYSE:AMN) Takes On Some Risk With Its Use Of Debt
Jun 09
AMN Healthcare: Trading At An Attractive Valuation For Long-Term Investors
May 29Results: AMN Healthcare Services, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 13AMN Healthcare: Where's The Stopping Point?
Apr 16AMN Healthcare Services, Inc. (NYSE:AMN) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
Feb 24The Market Doesn't Like What It Sees From AMN Healthcare Services, Inc.'s (NYSE:AMN) Earnings Yet
Dec 28AMN Healthcare Services (NYSE:AMN) Is Investing Its Capital With Increasing Efficiency
Sep 23AMN Healthcare: Close To Be A 'Buy'
Sep 21AMN Healthcare: Discounted Valuation But Lack Of Growth Makes It Reasonable
Jul 30AMN Healthcare Services (NYSE:AMN) Is Achieving High Returns On Its Capital
Jun 17Here's Why We Think AMN Healthcare Services (NYSE:AMN) Is Well Worth Watching
May 05Returns on Capital Paint A Bright Future For AMN Healthcare Services (NYSE:AMN)
Mar 03AMN Healthcare Q4 results beat estimates, co guides Q1 2023 revenue above consensus
Feb 16Here's Why We Think AMN Healthcare Services (NYSE:AMN) Is Well Worth Watching
Jan 31AMN, Cross Country fall as Jefferies cites lower temp staffing demand
Jan 18Does AMN Healthcare Services (NYSE:AMN) Have A Healthy Balance Sheet?
Jan 04A Look At The Fair Value Of AMN Healthcare Services, Inc. (NYSE:AMN)
Dec 21AMN Healthcare Services a new short idea at Hedgeye
Dec 20AMN Healthcare Services (NYSE:AMN) Could Become A Multi-Bagger
Nov 24AMN Healthcare: Earnings Upside, Return On Capital Key Factors In Investment Debate
Nov 08AMN Healthcare gets new key person
Oct 31Should You Be Adding AMN Healthcare Services (NYSE:AMN) To Your Watchlist Today?
Oct 24These 4 Measures Indicate That AMN Healthcare Services (NYSE:AMN) Is Using Debt Safely
Sep 27AMN Healthcare: Best Covid-19 Period Recoverer And Prospect For Near-Term Capital Gains
Aug 25Shareholders Would Enjoy A Repeat Of AMN Healthcare Services' (NYSE:AMN) Recent Growth In Returns
Aug 15AMN Healthcare Services Non-GAAP EPS of $3.31 beats by $0.32, revenue of $1.43B beats by $60M
Aug 04Estimating The Intrinsic Value Of AMN Healthcare Services, Inc. (NYSE:AMN)
Aug 01With EPS Growth And More, AMN Healthcare Services (NYSE:AMN) Makes An Interesting Case
Jul 19AMN Healthcare Services (NYSE:AMN) Seems To Use Debt Rather Sparingly
Jun 22AMN Healthcare Services: Limited Downside
Jun 11AMN Healthcare Services (NYSE:AMN) Could Become A Multi-Bagger
May 13Estimating The Intrinsic Value Of AMN Healthcare Services, Inc. (NYSE:AMN)
Apr 30Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 3,143 | 209 | 351 | 403 | 2 |
| 12/31/2025 | 2,995 | 83 | 297 | 280 | 9 |
| 12/31/2024 | 2,976 | 49 | 208 | 286 | 9 |
| 3/31/2024 | 3,484 | 144 | 304 | 410 | N/A |
| 12/31/2023 | 3,789 | 211 | 267 | 372 | N/A |
| 9/30/2023 | 4,096 | 280 | 430 | 529 | N/A |
| 6/30/2023 | 4,382 | 319 | 377 | 470 | N/A |
| 3/31/2023 | 4,817 | 382 | 412 | 497 | N/A |
| 12/31/2022 | 5,243 | 444 | 573 | 654 | N/A |
| 9/30/2022 | 5,481 | 478 | 545 | 616 | N/A |
| 6/30/2022 | 5,220 | 460 | 457 | 519 | N/A |
| 3/31/2022 | 4,651 | 403 | 411 | 466 | N/A |
| 12/31/2021 | 3,984 | 327 | 252 | 305 | N/A |
| 9/30/2021 | 3,252 | 220 | 218 | 267 | N/A |
| 6/30/2021 | 2,926 | 173 | 298 | 339 | N/A |
| 3/31/2021 | 2,677 | 128 | 209 | 245 | N/A |
| 12/31/2020 | 2,394 | 71 | 218 | 257 | N/A |
| 9/30/2020 | 2,349 | 89 | 256 | 296 | N/A |
| 6/30/2020 | 2,365 | 86 | 247 | 288 | N/A |
| 3/31/2020 | 2,292 | 93 | 196 | 240 | N/A |
| 12/31/2019 | 2,222 | 114 | 188 | 225 | N/A |
| 9/30/2019 | 2,164 | 122 | 168 | 205 | N/A |
| 6/30/2019 | 2,123 | 127 | 131 | 166 | N/A |
| 3/31/2019 | 2,146 | 133 | 165 | 203 | N/A |
| 12/31/2018 | 2,136 | 142 | 191 | 227 | N/A |
| 9/30/2018 | 2,117 | 147 | 192 | 226 | N/A |
| 6/30/2018 | 2,084 | 148 | 184 | 216 | N/A |
| 3/31/2018 | 2,016 | 143 | 149 | 176 | N/A |
| 12/31/2017 | 1,988 | 133 | N/A | 161 | N/A |
| 9/30/2017 | 1,967 | 118 | N/A | 149 | N/A |
| 6/30/2017 | 1,945 | 117 | N/A | 147 | N/A |
| 3/31/2017 | 1,929 | 112 | N/A | 141 | N/A |
| 12/31/2016 | 1,902 | 106 | N/A | 134 | N/A |
| 9/30/2016 | 1,817 | 100 | N/A | 85 | N/A |
| 6/30/2016 | 1,727 | 106 | N/A | 78 | N/A |
| 3/31/2016 | 1,604 | 96 | N/A | 83 | N/A |
| 12/31/2015 | 1,463 | 82 | N/A | 56 | N/A |
| 9/30/2015 | 1,340 | 72 | N/A | 61 | N/A |
| 6/30/2015 | 1,222 | 46 | N/A | 54 | N/A |
| 3/31/2015 | 1,123 | 38 | N/A | 36 | N/A |
| 12/31/2014 | 1,036 | 33 | N/A | 28 | N/A |
| 9/30/2014 | 1,005 | 32 | N/A | 38 | N/A |
| 6/30/2014 | 998 | 32 | N/A | 50 | N/A |
| 3/31/2014 | 1,001 | 33 | N/A | 63 | N/A |
| 12/31/2013 | 1,012 | 33 | N/A | 60 | N/A |
| 9/30/2013 | 1,011 | 31 | N/A | 63 | N/A |
| 6/30/2013 | 998 | 28 | N/A | 47 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: AMNDas prognostizierte Gewinnwachstum (18.2% pro Jahr) liegt über der Sparquote (2.4%).
Ertrag vs. Markt: AMNDie Erträge des Unternehmens (18.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (14.7% pro Jahr).
Hohe Wachstumserträge: AMNDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: AMNDie Einnahmen des Unternehmens werden in den nächsten 3 Jahren voraussichtlich zurückgehen (-1.8% pro Jahr).
Hohe Wachstumseinnahmen: AMNDie Einnahmen des Unternehmens werden in den nächsten drei Jahren voraussichtlich zurückgehen (-1.8% pro Jahr).
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: AMNDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (17.1 %).